[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 138 pages | ID: 27473ECB25BBEN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Pfizer Inc.
Merck & Co.
AstraZeneca
Serum Institute of India
Eli Lilly and Company
GlaxoSmithKline Plc
Sanofi S.A.
Beijing Minhai Biotechnology
Biogen Inc.
Baxter International Inc.

Major Types Covered
Single Dose Vial
Pre-filled Syringe

Major Applications Covered
For Children (2-10)
For Person (10-64)
For The old (?65)

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global 23-Valent Pneumococcal Polysaccharide Vaccine Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the 23-Valent Pneumococcal Polysaccharide Vaccine Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET-SEGMENTATION BY TYPE

5.1 Single Dose Vial
5.2 Pre-filled Syringe

6 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET-SEGMENTATION BY APPLICATION

6.1 For Children (2-10)
6.2 For Person (10-64)
6.3 For The old (?65)

7 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Pfizer Inc.
  8.1.1 Pfizer Inc. Profile
  8.1.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Pfizer Inc. Product/Solution Launches and Enhancements Analysis
  8.1.4 Pfizer Inc. Business Overview/Recent Development/Acquisitions
8.2 Merck & Co.
  8.2.1 Merck & Co. Profile
  8.2.2 Merck & Co. Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Merck & Co. Product/Solution Launches and Enhancements Analysis
  8.2.4 Merck & Co. Business Overview/Recent Development/Acquisitions
8.3 AstraZeneca
  8.3.1 AstraZeneca Profile
  8.3.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
  8.3.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.4 Serum Institute of India
  8.4.1 Serum Institute of India Profile
  8.4.2 Serum Institute of India Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Serum Institute of India Product/Solution Launches and Enhancements Analysis
  8.4.4 Serum Institute of India Business Overview/Recent Development/Acquisitions
8.5 Eli Lilly and Company
  8.5.1 Eli Lilly and Company Profile
  8.5.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Eli Lilly and Company Product/Solution Launches and Enhancements Analysis
  8.5.4 Eli Lilly and Company Business Overview/Recent Development/Acquisitions
8.6 GlaxoSmithKline Plc
  8.6.1 GlaxoSmithKline Plc Profile
  8.6.2 GlaxoSmithKline Plc Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 GlaxoSmithKline Plc Product/Solution Launches and Enhancements Analysis
  8.6.4 GlaxoSmithKline Plc Business Overview/Recent Development/Acquisitions
8.7 Sanofi S.A.
  8.7.1 Sanofi S.A. Profile
  8.7.2 Sanofi S.A. Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Sanofi S.A. Product/Solution Launches and Enhancements Analysis
  8.7.4 Sanofi S.A. Business Overview/Recent Development/Acquisitions
8.8 Beijing Minhai Biotechnology
  8.8.1 Beijing Minhai Biotechnology Profile
  8.8.2 Beijing Minhai Biotechnology Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Beijing Minhai Biotechnology Product/Solution Launches and Enhancements Analysis
  8.8.4 Beijing Minhai Biotechnology Business Overview/Recent Development/Acquisitions
8.9 Biogen Inc.
  8.9.1 Biogen Inc. Profile
  8.9.2 Biogen Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Biogen Inc. Product/Solution Launches and Enhancements Analysis
  8.9.4 Biogen Inc. Business Overview/Recent Development/Acquisitions
8.10 Baxter International Inc.
  8.10.1 Baxter International Inc. Profile
  8.10.2 Baxter International Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Baxter International Inc. Product/Solution Launches and Enhancements Analysis
  8.10.4 Baxter International Inc. Business Overview/Recent Development/Acquisitions

9 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Analysis from 2015-2020
10.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Analysis from 2015-2020
10.5 North America 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
10.6 North America 23-Valent Pneumococcal Polysaccharide Vaccine Value, Production and Market Share by Type (2015-2020)
10.7 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Value and Market Share by Application (2015-2020)
10.8 North America 23-Valent Pneumococcal Polysaccharide Vaccine by Country (United States, Canada)
  10.8.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
  10.8.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2015-2020)
10.9 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis

11 EUROPE

11.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Analysis from 2015-2020
11.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Analysis from 2015-2020
11.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
11.6 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value, Production and Market Share by Type (2015-2020)
11.7 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
  11.8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2015-2020)
11.9 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Production Analysis from 2015-2020
12.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Analysis from 2015-2020
12.5 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
12.6 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
  12.8.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2015-2020)
12.9 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Production Analysis from 2015-2020
13.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Analysis from 2015-2020
13.5 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
13.6 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Value, Production and Market Share by Type (2015-2020)
13.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
  13.8.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2015-2020)
13.9 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production Analysis from 2015-2020
14.4 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Analysis from 2015-2020
14.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
14.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
  14.8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2015-2020)
14.9 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET FROM 2020-2027

15.1 Future Forecast of the Global 23-Valent Pneumococcal Polysaccharide Vaccine Market from 2020-2027 Segment by Region
15.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value ($) and Growth Rate of 23-Valent Pneumococcal Polysaccharide Vaccine from 2015-2027
Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Segment by Product Type from 2015-2027
Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Segment by Application from 2015-2027
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Table Product Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Driving Factors for this Market
Table Industry News of 23-Valent Pneumococcal Polysaccharide Vaccine Market
Figure Value Chain Status of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Segment by Product Type from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Single Dose Vial of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Pre-filled Syringe of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Segment by Application from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) and Growth Rate Segment by Application from 2015-2020
Figure For Children (2-10) of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure For Person (10-64) of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure For The old (?65) of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Online Channel of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Pfizer Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Inc. Sales and Growth Rate from 2015-2020
Figure Pfizer Inc. Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Inc. 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co. Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co. Sales and Growth Rate from 2015-2020
Figure Merck & Co. Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co. 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Serum Institute of India Profile (Company Name, Plants Distribution, Sales Region)
Figure Serum Institute of India Sales and Growth Rate from 2015-2020
Figure Serum Institute of India Revenue ($) and Global Market Share from 2015-2020
Table Serum Institute of India 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly and Company Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly and Company Sales and Growth Rate from 2015-2020
Figure Eli Lilly and Company Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly and Company 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Plc Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Plc Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Plc Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Plc 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi S.A. Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi S.A. Sales and Growth Rate from 2015-2020
Figure Sanofi S.A. Revenue ($) and Global Market Share from 2015-2020
Table Sanofi S.A. 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Beijing Minhai Biotechnology Profile (Company Name, Plants Distribution, Sales Region)
Figure Beijing Minhai Biotechnology Sales and Growth Rate from 2015-2020
Figure Beijing Minhai Biotechnology Revenue ($) and Global Market Share from 2015-2020
Table Beijing Minhai Biotechnology 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biogen Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Biogen Inc. Sales and Growth Rate from 2015-2020
Figure Biogen Inc. Revenue ($) and Global Market Share from 2015-2020
Table Biogen Inc. 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Baxter International Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Baxter International Inc. Sales and Growth Rate from 2015-2020
Figure Baxter International Inc. Revenue ($) and Global Market Share from 2015-2020
Table Baxter International Inc. 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Value ($) by Region from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Value Share by Region from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Region from 2015-2020
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Region from 2015-2020
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) by Type (2015-2020)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Production by Type (2015-2020)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2015-2020)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Country (2015-2020)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) by Type (2015-2020)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production by Type (2015-2020)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2015-2020)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Country (2015-2020)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) by Type (2015-2020)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Production by Type (2015-2020)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2015-2020)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) by Type (2015-2020)
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Production by Type (2015-2020)
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020)
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2015-2020)
Table Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Country (2015-2020)
Figure Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export from 2015-2020
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) by Type (2015-2020)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production by Type (2015-2020)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2015-2020)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market PEST Analysis
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast by Region (2020-2027)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast by Type (2020-2027)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications